×
戻る Agenda
Session 2 (Parallel Session) : Patient Diversity, Equity and Inclusion in Clinical Trials and Regulatory Insights
Session Chair(s)
Yunni Lim, RPh
Country Leader of Global Clinical Operations / President, KCDA, Roche Korea Co Ltd, Korea, Republic of
Hye Jong Yoo, RPh
Executive Director, AstraZeneca , Korea, Republic of
Speaker(s)
Vanessa Cahee
Clinical Operations & Clinical Trial Diversity Consultant, VCahee Consulting LLC, United States
Seonghae Yoon, MD, PhD
, Seoul National University Bundang Hospital, Korea, Republic of
Monica Eason
Clinical Operations Portfolio Leader, Genentech, A Member of the Roche Group, United States
Pei-Chieh Fong
Vice President, Medical International, AstraZeneca Taiwan, Taiwan